Search This Blog

Monday, August 12, 2019

Akero Therapeutics EPS misses by $1.76

Akero Therapeutics (NASDAQ:AKRO): Q2 GAAP EPS of -$2.21 misses by $1.76.
Cash and cash equivalents of $162.6M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)